4 Results for "

A2780cis

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "A2780cis" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-124757
CAS No.: 932359-76-7
Purity:  99.87%
Target:  

Proteasome Mitosis

Research Areas:  

Cancer

FiVe1 is a vimentin (VIM) inhibitor. FiVe1 binds to the rod domain of VIM, causing metaphase VIM disassembly and hyperphosphorylation at Ser56, ultimately leading to mitotic catastrophe, multinucleation, and loss of stemness. FiVe1 has anticancer activity against soft tissue sarcomas. FiVe1 increases the sensitivity of ovarian cancer to Cisplatin (HY-17394). FiVe1 can be used for researches of mesenchymal cancers (including breast cancer and soft tissue sarcoma) and ovarian cancers .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-D2452
Cy3-Cisplatin is a Cyanine 3 fluorescent dye CY3 (HY-D0822) labled Cisplatin (HY-17394). Cy3-Cisplatin can be used for drug delivery, fluorescent labeling, cell imaging and tracking .
loading...
    loading...
Cat. No.: HY-162721
Research Areas:  

Cancer

Anticancer agent 242 (7) possesses anticancer activity in A2780 (IC50 = 0.24 μM, ovarian adenocarcinoma), A2780cis (IC50 = 0.45 μM, resistant derivative of A2780), CCD18Co (IC50 = 0.59 μM, non-malignant human fibroblasts), A549 (IC50 = 0.32 μM, lung carcinoma), HT29 (IC50 = 0.26 μM, colorectal adenocarcinoma), and MCF7 (IC50 = 0.55 μM, breast adenocarcinoma) .
loading...
    loading...
Cat. No.: HY-187179
Target:  

CDK Apoptosis

Research Areas:  

Cancer

CDK2-IN-62 is a predicted CDK2 inhibitor. CDK2-IN-62 induces apoptosis in breast cancer cells and reduces their colony-forming ability. CDK2-IN-62 can be used for the research of breast cancer, ovarian cancer and colorectal cancer .
loading...
    loading...